Navigation Links
Monoclonal Antibodies Market - New Industry Research Report is Now Available for Pre-Order at Transparency Market Research

Albany, New York (PRWEB) June 01, 2013

Monoclonal antibodies have brought a paradigm shift in biotechnology and pharmaceutical sectors. Monoclonal antibodies (mAbs) are mono-specific antibodies which comprise identical immune cells, and these immune cells are clones of a single parent cell and are distinguished by their unique property to bind to the same epitope.

Related Report : Collagen Peptide Market

Monoclonal antibodies are now used for treatment of a wide array of diseases, especially cancer, autoimmune, and inflammatory diseases. The development of these new molecular agents, successfully directed to specific cellular targets, is expected to play an increasingly important role in future clinical protocol, and perhaps finally provide a means to achieve long-term tolerance in human allograft recipients. The drugs are very specific for particular limited targets, since these do not enter the cells but only interact with them; hence they have limited application. Another difficulty faced using mAbs when compared to small molecule drugs is that they need to be injected.

The market analysis predicts growth for this market to be around USD 60 billion in the year 2012 and is predicted to have a double digit growth of around 15% from the year 2012 to 2018. Technological enhancements and huge R&D in genomic studies have propelled the growth of this market, with impressive number of mAbs entering the market since the last decade.

Related Report : Depression Drug Market

The major restraints for the growth of this market are high developmental costs which might reach around USD 1,000 million. Also, the longer duration required for developing these antibodies due to time consuming R&D and clinical trials makes it difficult to gain a faster entry in the market. However, rise in investments from venture capital funding organizations, federal government and big pharmaceutical companies is expected to further augment the growth of this market and is anticipated to help in overcoming the challenges faced by this industry.

Some of the major companies in this industry segment are Roche, Genentech, Eli Lilly, Biogen Idec, Bristol Myers Squibb, Pfizer and others.

Related Report : Antipsychotic Drugs Market

This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include

North America
Asia Pacific
Rest of the World
This report provides comprehensive analysis of
Market growth drivers
Factors limiting market growth
Current market trends
Market structure
Market projections for upcoming years

This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.

Browse Report with Request TOC :

Reasons for Buying this Report

This report provides pin-point analysis for changing competitive dynamics
It provides a forward looking perspective on different factors driving or restraining market growth
It provides a technological growth map over time to understand the industry growth rate
It provides a seven-year forecast assessed on the basis of how the market is predicted to grow
It helps in understanding the key product segments and their future
It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments
It provides distinctive graphics and exemplified SWOT analysis of major market segments

Browse All Market Research Reports:

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Monoclonal antibody appears effective and safe in asthma Phase IIa trial
2. New monoclonal antibody inhibits tumor growth in advanced solid tumors in phase I clinical trial
3. Research reveals how antibodies neutralize mosquito-borne virus
4. Genetically modified tobacco plants produce antibodies to treat rabies
5. NIH scientists identify protective role for antibodies in Ebola vaccine study
6. Scripps Research scientists devise powerful new method for finding therapeutic antibodies
7. Autoantibodies damage blood vessels in the brain
8. Antibodies for new rotavirus vaccines
9. Antibodies from rabbits reduce risks associated with unrelated donor stem cell transplantation
10. Antibodies from rabbits reduce risks associated with
11. Antibodies reverse type 1 diabetes in new immunotherapy study
Post Your Comments:
(Date:6/27/2016)... ... June 27, 2016 , ... ... announced today its affiliation with Tennessee Counseling Association. This new relationship ... of the Tennessee Counseling Association, adding exclusive benefits and promotional offers. , "TCA ...
(Date:6/26/2016)... ... June 26, 2016 , ... On June 10-11, 2016, A Forever Recovery, a ... and World’s Longest Breakfast Table in Battle Creek, MI, where the rehabilitation facility is ... to some of the world’s leading providers of cereal and other breakfast foods. Its ...
(Date:6/25/2016)... ... June 25, 2016 , ... Experts from the American ... Annual Research Meeting June 26-28, 2016, at the Hynes Convention Center in Boston. ... including advance care planning, healthcare costs and patient and family engagement. , AIR ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern ... Laude and his M.D from the David Geffen School of Medicine at UCLA. He ... Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... Those who ... with these feelings, many turn to unhealthy avenues, such as drug or alcohol abuse, ... Marne, Michigan, has released tools for healthy coping following a traumatic event. , Trauma ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... 2016 Research and Markets has announced ... Analysis 2016 - Forecast to 2022" report to their ... contains up to date financial data derived from varied research ... trends with potential impact on the market during the next ... which comprises of sub markets, regional and country level analysis. ...
(Date:6/23/2016)... , , , WHEN: ... , , , , LOCATION: , , , Online, with ... , EXPERT PANELISTS:  , , , Frost & Sullivan,s Global Vice ... Senior Industry Analyst, Divyaa Ravishankar and Unmesh Lal, Program Manager , ... industry is witnessing an exceptional era. Several new demand spaces, such ...
(Date:6/23/2016)... -- Guerbet announced today that it has been named a ... One of 12 suppliers to receive the ... of Premier members through exceptional local customer service and ... lower costs. "We ... customer service from Premier," says Massimo Carrara , ...
Breaking Medicine Technology: